What is a stock summary page? Click here for an overview.
Business Description
Medipost Co Ltd
ISIN : KR7078160009
Share Class Description:
XKRX:078160: Ordinary SharesCompare
Compare
Traded in other countries / regions
078160.KoreaMEPTF.USA Index Membership
KOSDAQ Composite Index IPO Date
2005-07-29Description
Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.36 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -0.2 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.58 | |||||
| Beneish M-Score | -2.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -11.3 | |||||
| 3-Year EPS without NRI Growth Rate | -184.2 | |||||
| 3-Year FCF Growth Rate | -48.9 | |||||
| 3-Year Book Growth Rate | -4.7 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.4 | |||||
| 9-Day RSI | 55.34 | |||||
| 14-Day RSI | 51.99 | |||||
| 3-1 Month Momentum % | -21.19 | |||||
| 6-1 Month Momentum % | 39.06 | |||||
| 12-1 Month Momentum % | 29.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.66 | |||||
| Quick Ratio | 1.46 | |||||
| Cash Ratio | 1.14 | |||||
| Days Inventory | 205.58 | |||||
| Days Sales Outstanding | 61.02 | |||||
| Days Payable | 23.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22.1 | |||||
| Shareholder Yield % | 7.26 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.47 | |||||
| Operating Margin % | -68.7 | |||||
| Net Margin % | -88.49 | |||||
| FCF Margin % | -57.36 | |||||
| ROE % | -21.34 | |||||
| ROA % | -14.38 | |||||
| ROIC % | -14.96 | |||||
| 3-Year ROIIC % | -40.02 | |||||
| ROC (Joel Greenblatt) % | -45.21 | |||||
| ROCE % | -16.82 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.22 | |||||
| PB Ratio | 1.18 | |||||
| Price-to-Tangible-Book | 1.21 | |||||
| EV-to-EBIT | -3.5 | |||||
| EV-to-EBITDA | -3.87 | |||||
| EV-to-Revenue | 3.09 | |||||
| EV-to-FCF | -5.23 | |||||
| Price-to-GF-Value | 1.16 | |||||
| Price-to-Projected-FCF | 3.62 | |||||
| Price-to-Median-PS-Value | 0.34 | |||||
| Earnings Yield (Greenblatt) % | -28.58 | |||||
| FCF Yield % | -13.53 | |||||
| Forward Rate of Return (Yacktman) % | -22.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medipost Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 70,657.029 | ||
| EPS (TTM) (â‚©) | -1834 | ||
| Beta | 0.58 | ||
| 3-Year Sharpe Ratio | -0.39 | ||
| 3-Year Sortino Ratio | -0.52 | ||
| Volatility % | 56.47 | ||
| 14-Day RSI | 51.99 | ||
| 14-Day ATR (â‚©) | 415.212603 | ||
| 20-Day SMA (â‚©) | 8434 | ||
| 12-1 Month Momentum % | 29.42 | ||
| 52-Week Range (â‚©) | 5450 - 15180 | ||
| Shares Outstanding (Mil) | 34.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medipost Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medipost Co Ltd Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medipost Co Ltd Frequently Asked Questions
What is Medipost Co Ltd(XKRX:078160)'s stock price today?
The current price of XKRX:078160 is â‚©8780.00. The 52 week high of XKRX:078160 is â‚©15180.00 and 52 week low is â‚©5450.00.
When is next earnings date of Medipost Co Ltd(XKRX:078160)?
The next earnings date of Medipost Co Ltd(XKRX:078160) is .
Does Medipost Co Ltd(XKRX:078160) pay dividends? If so, how much?
Medipost Co Ltd(XKRX:078160) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers